CN102178875A - Traditional Chinese pill used for treating liver disease - Google Patents
Traditional Chinese pill used for treating liver disease Download PDFInfo
- Publication number
- CN102178875A CN102178875A CN2011100961058A CN201110096105A CN102178875A CN 102178875 A CN102178875 A CN 102178875A CN 2011100961058 A CN2011100961058 A CN 2011100961058A CN 201110096105 A CN201110096105 A CN 201110096105A CN 102178875 A CN102178875 A CN 102178875A
- Authority
- CN
- China
- Prior art keywords
- pill
- medicine
- traditional chinese
- liver
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006187 pill Substances 0.000 title claims abstract description 17
- 208000019423 liver disease Diseases 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 29
- 235000021419 vinegar Nutrition 0.000 claims abstract description 11
- 239000000052 vinegar Substances 0.000 claims abstract description 11
- 206010023126 Jaundice Diseases 0.000 claims abstract description 10
- 206010019799 Hepatitis viral Diseases 0.000 claims abstract description 6
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 201000001862 viral hepatitis Diseases 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 210000004185 liver Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 230000003908 liver function Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 102000003929 Transaminases Human genes 0.000 abstract description 6
- 108090000340 Transaminases Proteins 0.000 abstract description 6
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 206010019668 Hepatic fibrosis Diseases 0.000 abstract description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 2
- 244000135727 Abrus pulchellus subsp cantoniensis Species 0.000 abstract 1
- 235000017112 Abrus pulchellus subsp cantoniensis Nutrition 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000286838 Eclipta prostrata Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000208672 Lobelia Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000994 depressogenic effect Effects 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 244000153234 Hibiscus abelmoschus Species 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000037319 Hepatitis infectious Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000005252 hepatitis A Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000006793 Artemisia stelleriana Nutrition 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 240000005308 Juniperus chinensis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000006413 coastal sagewort Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003910 liver physiology Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese pill used for treating level disease, in particular to a traditional Chinese medicine for treating virus hepatitis jaundice and preventing liver disease. The pill consists of 20 traditional Chinese medicines: Astragalus mongholicus, Codonopsis pilosula, white atractylodes rhizome, vinegar Bupleurum, radix paeoniae alba, tarragon, Polygonum multiflorum, Smilax glabra, angelica, the root of red-rooted salvia, Schisandra, Eclipta prostrata, Thunberg Fritillary Bulb, trichosanthes kirilowii Maxim, oysters, Scutellaria baicalensis, rhizoma polygonati, lobelia, Abrus cantoniensis Hance and licorice. The production method of the medicine is implemented according to the production process of water-bindered pill. The pill has the efficacies of soothing the liver and regulating vital energy, tonifying spleen and clearing damp, clearing heat and detoxicating, tonifying Qi and blood, nourishing yin and suppressing yang, promoting blood circulation and removing blood stasis, and can improve the immune ability of patients, reduce transaminase, recover liver function, resist hepatic fibrosis and achieve the aim of strengthening the body resistance to eliminate pathogenic factors. For the medicine, the effective rate is 92% and the cure rate is 80%.
Description
Technical field
The present invention relates to a kind of medicine pill for the treatment of hepatopathy, particularly relate to a kind of Chinese medicine for the treatment of viral hepatitis jaundice and prevention of liver disease.
Background technology
Viral hepatitis system is by the caused a kind of infectious disease of the digestive tract of hepatitis virus.Doctor trained in Western medicine generally is divided into acute icteric, non-icteric type and delay property and chronic hepatitis.From seeing that clinically primary disease belongs to the category of diseases such as the traditional Chinese medical science " jaundice ", " costalgia ", " gathering ", " irritability "." a Ling Shu Miraculous Pivot or Divine Axis five pathogenic factors piece of writing " " has heresy liver, then pain in two sides of body "." element asks specimen the sick opinion that passes " has again: " hepatopathy dizziness, discomfort and fullness in the hypochondrium, three daily weight general pains, five days and expand ... ".And " Medical Treasures of the Golden Chamber " is as calling: " sick jaundice, fever with restlessness and dyspnea, fullness in the chest and parched mouth person ... ", and " complaining of restlessness and discomfort in the extremities, the spleen color must be yellow, accumulated heat being dispersed ... ".The symptom something in common of hepatopathy for feel sick, inappetence, breast abdomen rise by vexed, fatiguability, heating cold perspiration, uncomfortable liver area or pain, dull pain, abnormal liver function, hepatosplenomegaly etc.It is more that method side's medicine for the treatment of hepatopathy is gone up by society at present, and some is cured the symptoms, not the disease, and side effect is big, and therapeutic effect is not ideal enough and the medicine high price is expensive.The inventor has fully studied the traditional medicine of motherland again on the basis of inheriting forefathers, proposed the present invention.
Summary of the invention
The object of the present invention is to provide that a kind of treatment cycle is short, side effect is less, curative effect is high, do not have and return jumping, low, the effective percentage 92% of price, cure rate 80%.The present invention has the effect of depressed liver-energy dispersing and QI regulating invigorating the spleen to clear away damp pathogen, heat-clearing and toxic substances removing, benefiting vital QI and blood, nourishing YIN for suppressing the hyperactive YANG, blood circulation promoting and blood stasis dispelling, can improve patient's immunocompetence, and transaminase lowering recovers liver function, and the effect of anti-hepatic fibrosis reaches the purpose of strengthening vital QI to eliminate pathogenic factors.Be used for the treatment of viral hepatitis jaundice, liver cirrhosis.
The present invention addresses the above problem the technical scheme (consumption is gram) that adopts:
The preparing process of medicine of the present invention:
Earlier Radix Bupleuri is gone into pot, fry after the spray vinegar do standby, the ratio of Radix Bupleuri and vinegar 10: 1, dry respectively after the 19 flavor Chinese medicine roguings with remainder then, reinstate pulverizer with Radix Bupleuri (processed with vinegar) one then and be ground into smalls, it is standby to cross 100 mesh sieves then, machine is made pill and is got final product at last.When preparing this pill, add conventional pharmaceutically acceptable auxiliaries as required, those skilled in the art carries out according to practical situation, and for the concrete selection of adjuvant, the present invention does not have specific restriction.
The instructions of taking of medicine of the present invention: pill is for taking after mixing it with water, and every day, the 20-30 gram divided morning and evening secondary warm water to take after mixing it with water, and serveing on three months was 1 course of treatment, and cure 2-3 the course of treatment, effective percentage 92%, and cure rate 80% is quitted smoking and is given up alcohol.
Pharmacological action: advantage of the present invention is that pure Chinese medicine prepares traditionally, reliable effectively in ladies and gentlemen's medicine, according to Chinese medicine and theory, be and have no side effect, and does not also have the taboo of compatibility aspect.This prescription has the effect of depressed liver-energy dispersing and QI regulating invigorating the spleen to clear away damp pathogen, heat-clearing and toxic substances removing, benefiting vital QI and blood, nourishing YIN for suppressing the hyperactive YANG, blood circulation promoting and blood stasis dispelling, can improve patient's immunocompetence, and transaminase lowering recovers liver function, and the effect of anti-hepatic fibrosis reaches the purpose of strengthening vital QI to eliminate pathogenic factors.The Radix Astragali, " herbal justice ": " Radix Astragali, soil in the tonification, the replenishing vital QI with drugs of warm nature taste, all middle gas is depressed, and sagging person is the most suitable for the weak clearing heat in QI system of spleen soil." Radix Astragali can promote human body to produce interferon, effectively suppresses duplicating of hepatitis B virus and HBV-DNA; The Radix Codonopsis invigorating the spleen and replenishing QI is promoted the production of body fluid, and the Rhizoma Atractylodis Macrocephalae strengthens the spleen and stomach, dampness and in, control weakness of the spleen and stomach, deficiency-distension, jaundice, this two the flavor medicine can strengthen patient's muscle power.Radix Bupleuri (processed with vinegar) has depressed liver-energy dispersing and QI regulating, and the effect of function of gallbladder promoting is controlled fullness in the chest and hypochondriac pain; The Radix Paeoniae Alba goes into liver spleen two warps, and bitter in the mouth acid has the slow middle pain relieving of nourishing blood to suppress the hyperactive liver, controls the breast abdomen pain over the hypochondriac region; Herba Artemisiae Scopariae is gone into Liver and kidney two warps, and clearing away heat-damp and promoting diuresis is controlled the jaundice due to damp-heat dysuria, and this medicine has the liver cell regeneration of promotion effect, and swollen the dwindling of jaundice disappearance regulating liver-QI had obvious effects; The Radix Polygoni Multiflori nourishing the liver and kidney improves immunocompetence; Rhizoma Smilacis Glabrae has the effect of detoxifcation dehumidifying; Radix Angelicae Sinensis has the effect of the promoting the circulation of blood of enriching blood; Radix Salviae Miltiorrhizae has the effect of blood circulation promoting and blood stasis dispelling clearing heat and relieving fidgetness; Radix Salviae Miltiorrhizae can improve the liver physiology function to delay property and chronic hepatitis; impel liver and spleen retraction and deliquescing; to add the Moschus moschiferous unusual person's recovery situation of wadding a quilt with cotton unusually or better with turbid two of transaminase, Moschus moschiferous for liver function recovery; transaminase, Moschus moschiferous are turbid, the brain wadding has unusual person to take second place, and four all unusual persons are relatively poor.Fructus Schisandrae Chinensis has the effect that nourishing kidney is promoted the production of body fluid, and the energy transaminase lowering; The Herba Ecliptae nourishing the liver and kidney; Bulbus Fritillariae Thunbergii has the effect of removing heat-phlegm powder detoxifcation; The Chinese juniper beach wormwood has antibiotic antitumaous effect, and the hepatic ascites cancerous cell is had lethal effect.Concha Ostreae has the effect of yin fluid astringing YANG hyperactivity suppressing, resolving phlegm and softening hard masses, controls goiter.Radix Scutellariae has the removing the relative excess fire and removes damp and hot effect, the subcutaneous ulcer of harnessing the Yellow River, and infectious hepatitis can make liver power recovery normal, can reduce glutamate pyruvate transaminase; Rhizoma Polygonati invigorating the spleen and replenishing QI bone and muscle strengthening, the empty lack of appetite of back body of curing the disease can strengthen patient's immunity of organisms; Herba Lobeliae Chinensis inducing diuresis to remove edema heat-clearing and toxic substances removing treating the liver ascites; Herba Abri has heat-clearing and toxic substances removing soothing liver-QI dissipating blood stasis harness the Yellow River subcutaneous ulcer hepatitis, infectious hepatitis, has the jaundice of disappearing, and recovers the effect of liver function; The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.
Clinical efficacy standard and therapeutic outcome:
Physical data: select for use case from 2005-2008 totally 300 routine viral hepatitis, many age brackets of wherein falling ill all have clinical symptoms: loss of appetite, feel sick, asthenia, abdominal distention, hepatomegaly and liver function injury in various degree.
Therapeutic Method: utilize medicine of the present invention to add the flavor treatment to the ill, usage secondary every day, each 12 grams, serveing on 3 months is a course of treatment, general treatment 3-4 is about a course of treatment.Criterion of therapeutical effect: cure: after taking 3 courses of treatment, clinical symptoms and characteristic disappear are followed up a case by regular visits to and are not had recurrence half a year; Take a turn for the better: take medicine after 3 courses of treatment, sings and symptoms is clearly better, and takes to reach the clinical cure standard 2 courses of treatment again; Invalid: take medicine after 3 courses of treatment, symptom and sign do not have obvious transformation.
Therapeutic outcome: in 300 examples, healing person's 240 examples (accounting for 80%); 36 examples that take a turn for the better (accounting for 12%); Invalid 24 examples (accounting for 8%).
The specific embodiment
A kind of its prescription of medicine pill for the treatment of hepatopathy is formed in the present embodiment
Preparing process:
Earlier Radix Bupleuri is gone into pot, fry after the spray vinegar do standby, the ratio of Radix Bupleuri and vinegar 10: 1, dry respectively after the 19 flavor Chinese medicine roguings with remainder then, reinstate pulverizer with Radix Bupleuri (processed with vinegar) one then and be ground into smalls, it is standby to cross 100 mesh sieves then, machine is made pill and is got final product at last.When preparing this pill, add conventional pharmaceutically acceptable auxiliaries as required, those skilled in the art carries out according to practical situation, and for the concrete selection of adjuvant, the present invention does not have specific restriction.
The instructions of taking of medicine of the present invention: pill is for taking after mixing it with water, and every day, the 20-30 gram divided morning and evening secondary warm water to take after mixing it with water, and serveing on three months was 1 course of treatment, and cure 2-3 the course of treatment, effective percentage 92%, and cure rate 80% is quitted smoking and is given up alcohol.
Claims (2)
1. a medicine pill for the treatment of hepatopathy particularly relates to a kind of Chinese medicine for the treatment of viral hepatitis jaundice and prevention of liver disease, it is characterized in that its composition is (unit: restrain) by weight:
2. according to the described a kind of medicine pill for the treatment of hepatopathy of claim 1, its preparing process is characterised in that: earlier Radix Bupleuri is gone into pot, fry dried standby after the spray vinegar, the ratio of Radix Bupleuri and vinegar 10: 1, dry respectively after the 19 flavor Chinese medicine roguings with remainder then, then reinstate pulverizer with Radix Bupleuri (processed with vinegar) one and be ground into smalls, it is standby to cross 100 mesh sieves then, and last machine is made pill and got final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100961058A CN102178875A (en) | 2011-04-18 | 2011-04-18 | Traditional Chinese pill used for treating liver disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100961058A CN102178875A (en) | 2011-04-18 | 2011-04-18 | Traditional Chinese pill used for treating liver disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102178875A true CN102178875A (en) | 2011-09-14 |
Family
ID=44565281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100961058A Pending CN102178875A (en) | 2011-04-18 | 2011-04-18 | Traditional Chinese pill used for treating liver disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102178875A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441147A (en) * | 2011-12-20 | 2012-05-09 | 北京天科仁祥医药科技有限公司 | Chinese medicinal compound preparation for treating chronic hepatitis |
| CN103083595A (en) * | 2013-02-04 | 2013-05-08 | 上海浦东高星生物技术研究所 | Ganyanling granules |
| CN103212033A (en) * | 2013-04-27 | 2013-07-24 | 郑法海 | Drug composition for treating viral hepatitis |
| CN103655882A (en) * | 2013-12-18 | 2014-03-26 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition for treating hepatitis C and preparation method of composition |
| CN104547785A (en) * | 2014-12-25 | 2015-04-29 | 韦邦力 | Traditional Chinese medicine for treating hepatitis |
| CN106110212A (en) * | 2016-08-11 | 2016-11-16 | 亳州市益众堂保健食品有限公司 | A kind of Herba Artemisiae Scopariae tea preventing hepatitis and preparation method thereof |
| CN107789450A (en) * | 2016-08-30 | 2018-03-13 | 天津太平洋制药有限公司 | A kind of medicine for treating hepatic sclerosis and preparation method thereof |
| CN110215495A (en) * | 2019-07-15 | 2019-09-10 | 李国伦 | A kind of drug improved the immunity of the human body |
| CN113908208A (en) * | 2021-09-14 | 2022-01-11 | 北京大北农动物保健科技有限责任公司 | Liver-protecting pharmaceutical composition and preparation method and application thereof |
-
2011
- 2011-04-18 CN CN2011100961058A patent/CN102178875A/en active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441147A (en) * | 2011-12-20 | 2012-05-09 | 北京天科仁祥医药科技有限公司 | Chinese medicinal compound preparation for treating chronic hepatitis |
| CN103083595A (en) * | 2013-02-04 | 2013-05-08 | 上海浦东高星生物技术研究所 | Ganyanling granules |
| CN103212033A (en) * | 2013-04-27 | 2013-07-24 | 郑法海 | Drug composition for treating viral hepatitis |
| CN103655882A (en) * | 2013-12-18 | 2014-03-26 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition for treating hepatitis C and preparation method of composition |
| CN103655882B (en) * | 2013-12-18 | 2015-05-20 | 北京亚东生物制药有限公司 | Traditional Chinese medicine composition for treating hepatitis C and preparation method of composition |
| CN104547785A (en) * | 2014-12-25 | 2015-04-29 | 韦邦力 | Traditional Chinese medicine for treating hepatitis |
| CN106110212A (en) * | 2016-08-11 | 2016-11-16 | 亳州市益众堂保健食品有限公司 | A kind of Herba Artemisiae Scopariae tea preventing hepatitis and preparation method thereof |
| CN107789450A (en) * | 2016-08-30 | 2018-03-13 | 天津太平洋制药有限公司 | A kind of medicine for treating hepatic sclerosis and preparation method thereof |
| CN110215495A (en) * | 2019-07-15 | 2019-09-10 | 李国伦 | A kind of drug improved the immunity of the human body |
| CN113908208A (en) * | 2021-09-14 | 2022-01-11 | 北京大北农动物保健科技有限责任公司 | Liver-protecting pharmaceutical composition and preparation method and application thereof |
| CN113908208B (en) * | 2021-09-14 | 2024-02-09 | 北京大北农动物保健科技有限责任公司 | Liver-protecting pharmaceutical composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178875A (en) | Traditional Chinese pill used for treating liver disease | |
| CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN104338043B (en) | A kind of medicine for improving immunity and preparation method thereof | |
| CN104383390A (en) | Chinese traditional medicine preparation for treating lung cancer | |
| CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
| CN104306766B (en) | Prevent and treat Chinese medicinal formulae of patients with radioactive mucositis of oral cavity and preparation method thereof | |
| CN103550696B (en) | Medicine for treating lung cancer | |
| CN102327572B (en) | Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof | |
| CN105126043A (en) | Traditional Chinese medicine composition for treating liver cirrhosis and application thereof | |
| CN104758711A (en) | Chinese herba preparation for treating pulmonary sarcoidosis and preparing method thereof | |
| CN101890146A (en) | Traditional Chinese medicine pills for treating liver diseases | |
| CN101433695B (en) | Medicament for treating liver disease | |
| CN103169894B (en) | Traditional Chinese medicine composition for treating proteinuria | |
| CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine | |
| CN104825929A (en) | Chinese herbal medicine for treating children's dyspepsia | |
| CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
| CN103623354B (en) | Traditional Chinese medicinal preparation for treating retroperitoneal follicular dendritic cell sarcoma | |
| CN103784720A (en) | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose | |
| CN104971340B (en) | A kind of Chinese medicine preparation and preparation method thereof for treating diarrhea associated with menstruation | |
| CN103860735B (en) | The Chinese medicine, Chinese medicine composition and preparation method thereof for the treatment of sciatica and lumbago | |
| CN103550541A (en) | Traditional Chinese medicine composition for treating chronic hepatitis | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN102166303B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis | |
| CN102872293A (en) | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110914 |